Highly purified omega-3 fatty acid ethyl-esters:
What do the data tell us?
30-Aug-11
, Paris, France
Highly purified omega-3 fatty acid ethyl-esters: Adding benefits in cardiovascular risk prevention
29-Aug-10
, Stockholm, Sweden
New perspectives for an evidence-based therapy with omega-3 fatty acid ethyl esters
02-Sep-08
, Munich, Germany
Cerebro- and Cardiovascular Risk Reduction with Eprosartan
04-Sep-06
, Barcelona, Spain
